What is Enliven Therapeutics's debt-to-equity?

Enliven Therapeutics (ELVN) reported debt-to-equity of 0× in Q1 2026.

How has Enliven Therapeutics's debt-to-equity changed year-over-year?

Enliven Therapeutics's debt-to-equity decreased by 70.8% year-over-year, from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Enliven Therapeutics ELVN Debt-to-equity

Debt-to-equity at other companies

Bristol-Myers SquibbBMY

2.2×-0.6×

PfizerPFE

0.7×0.0×

Relay Therapeutics, Inc.RLAY

0×0.0×

Arcus BiosciencesRCUS

0.2×+0.1×

Intellia TherapeuticsNTLA

0.1×0.0×

ExelixisEXEL

0.1×0.0×

Other financials

Income statement

See full

Operating income-$27.8M+12.2%

Net income-$23.6M+17.2%

EPS (diluted)-$0.38+33.3%

Balance sheet

See full

Cash & equivalents$132.2M+30.0%

Total debt$302.0K-56.9%

Total equity$453.4M+57.3%

Total assets$464.9M+53.6%

Cash flow

See full

Operating cash flow-$19.3M+20.0%

CapEx--100%

Free cash flow-$19.3M+20.1%

Valuation

See full

Market cap$3.47B+143%

Enterprise value$3.34B+156%

Returns & leverage

See full

Return on equity-26.6%-3.5pp

Current ratio40.3×+19.3×

Where this comes from

Calculated from Enliven Therapeutics’s reported figures.

total debt/total stockholders equity=0×

Based on the most recent quarter.

The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enliven Therapeutics's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enliven Therapeutics's debt-to-equity?: Enliven Therapeutics (ELVN) reported debt-to-equity of 0× in Q1 2026.
How has Enliven Therapeutics's debt-to-equity changed year-over-year?: Enliven Therapeutics's debt-to-equity decreased by 70.8% year-over-year, from 0× to 0×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.